Evaluation of Cyfra 21-1: A potential tumor marker for non-small cell lung carcinomas

Lung

Volumn 179, Issue 1, 2001, Pages 57-65

  Karnak, D ^a   Ulubay, G ^a   Kayacan, O ^a   Beder, S ^a   Ibis, E ^a   Oflaz, G ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Cyfra 21 1; Lung carcinoma; Non small cell lung carcinoma

Indexed keywords

CYTOKERATIN 19 FRAGMENT; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CARCINOMA IN SITU; CELL DIFFERENTIATION; EPITHELIUM CELL; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNORADIOMETRIC ASSAY; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROGNOSIS;

ANALYSIS OF VARIANCE; ANTIGENS, NEOPLASM; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; KERATINS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 0034914063     PISSN: 03412040     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004080000047     Document Type: Article

References (18)

1. Utility of serum cytokeratin 19 fragment (CYFRA 21-1) and carcinoembryonic antigen (CEA) as tumour markers for non-small cell lung cancer
2. Does the assessment of serum markers in patients with lung cancer aid in the clinical decision-making process?
3. Lung cancer
4. Serum tumor markers in lung cancer: History, biology and clinical applications
5. Prognosis in bronchogenic squamous cell carcinoma groups divided according to serum squamous cell carcinoma-related antigen and cytokeratin 19 fragment levels
6. Stem cell factor (SCF) in diagnosis and monitoring of non-small cell lung cancer
7. Diagnostic and prognostic value of the new tumor marker Cyfra 21-1 in patients with squamous cell lung cancer
8. Evaluation of tissue polypeptide specific antigen, Cyfra 21-1, and carcinoembryonic antigen in non-small cell lung carcinoma: Does the combined use of cytokeratin markers give any additional information?
9. Discriminant analysis of small cell lung cancer and non-small cell lung cancer by means of NSE and Cyfra 21-1
10. The concentrations of five tumor markers in both BAL fractions in lung cancer patients in relation to cigarette smoking
11. Epidemiology of lung cancer
12. Cyfra 21-1 as a tumor marker for bronchogenic carcinoma
13. Cyfra 21-1: A sensitive and specific new tumor marker for squamous cell lung cancer. Report of the first European multicentre evaluation
14. Comparison of Cytokeratin fragment 19 (Cyfra 21-1), tissue polypeptide antigen (TPA) and tissue polypeptide specific antigen (TPS) as tumor markers in lung cancer
15. Cyfra 21-1: A new marker in lung cancer
16. Cytokeratin fragment 19 and squamous cell carcinoma antigen for early prediction of recurrence of squamous cell lung carcinoma
17. Pre-treatment evaluation of non-small cell lung cancer